50423-23-9

Upstream product

• 4780-63-6 3,5-dihydroxy-2-methylbenzoic acid 
• 77-78-1 dimethyl sulfate 
• 118-90-1 ortho-methylbenzoic acid 
• 216451-88-6 2-methyl-3,5-disulfo-benzoic acid 
• 81633-93-4 5-ethyl-4-methyl-resorcinol 
• 52344-94-2 methyl 3,5-dimethoxy-2-methylbenzoate 

Downstream Products

• 708286-44-6 1-(3,5-dimethoxy-2-methyl-phenyl)-ethanone 
• 856999-42-3 3,5-dimethoxy-2-methyl-benzoic acid amide 
• 861056-89-5 (3,5-dimethoxy-2-methyl-phenyl)-acetic acid amide 
• 95816-92-5 1-sec-butyl-2-methyl-3,5-bis-(4-nitro-benzoyloxy)-benzene 
• 92101-93-4 1-sec-butyl-3,5-dimethoxy-2-methyl-benzene 
• 91968-74-0 5-sec-butyl-4-methyl-resorcinol 
• 52344-95-3 (3,5-dimethoxy-2-methyl-phenyl)-acetonitrile 
• 81633-93-4 5-ethyl-4-methyl-resorcinol 

Relevant academic research and scientific papers

Adamantane derivatives

The invention provides adamantane derivatives, a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy.

Adamantane derivatives

The invention provides adamantane derivatives, a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy.